FDA inspection

AptaPharma Inc.: FDA inspection ending May 15, 2023

FDA inspection 1205203 · Voluntary Action Indicated (VAI) · Pennsauken, NJ

Key facts

Inspection ID 1205203
Firm AptaPharma Inc.
FEI number 3010164738
Address 1533 Union Ave
City Pennsauken
State NJ
ZIP 08110-2489
Fiscal year 2023
Inspection end date May 15, 2023
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections